Pieris Pharmaceuticals Retained Earnings (Accumulated Deficit) 1970-1969 | PVLA
Pieris Pharmaceuticals retained earnings (accumulated deficit) from 1970 to 1969. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Pieris Pharmaceuticals Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
